Nationally Recognized Heart Hospital
Dallas   Fort Worth



Find a Physician

Advanced Search


DISRUPT CAD III

DISRUPT CAD III
A study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System(*) in de novo, calcified, stenotic, coronary arteries prior to stenting.
*This device is approved for investigational use only in the U.S.

This is a prospective, multicenter, single-arm, global IDE study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic, coronary arteries prior to stenting.

"Current treatment for deep calcium in coronary and peripheral arteries is suboptimal with today's technology. Cardiologists and vascular physicians are seeing more and more patients with calcified disease, particularly elderly patients or those with diabetes and chronic kidney disease. The Shockwave device being evaluated in this trial uses intravascular lithotripsy, a similar therapy used to break up kidney stones, and could prove to safely dilate deep calcium." says Robert Stoler, MD, principal investigator.

Inclusions/Exclusions:
Please contact the research coordinator for the exclusions: Emily Laible, RN, BSN, CCRC, at 214-820-9903 or email at Emily.Laible@BSWHealth.org.

Additional information may be found for this study, DISRUPT CAD III, at:
https://www.clinicaltrials.gov/ct2/show/NCT03595176?term=DISRUPT+CAD+III+STUDY&rank=1

Primary Investigator:
Robert M. Stoler, MD, FACC, FSCAI

For more information, please contact: Emily Laible, RN, BSN, CCRC, at 214-820-9903 or email at Emily.Laible@BSWHealth.org.

Back to Clinical Trials

Warning

Your Session will expire in 5 minutes

Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.